title: Primary conjunctival follicular lymphoma treated with the anti-CD20 antibody rituximab and low-dose involved-field radiotherapy.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Takahira
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Okumura
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Minato
authors.forename: Norimasa
authors.initials: N
authors.lastname: Urushisaki
authors.forename: Mayumi
authors.initials: M
authors.lastname: Sakurai
authors.forename: Kazuhisa
authors.initials: K
authors.lastname: Sugiyama
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D003131:Combined Modality Therapy; D003230:Conjunctival Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab